(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 44.24%4.62B | 69.45%2.81B | 1.50%570.79M | 91.34%5.61B | 148.15%3.2B | 67.66%1.66B | 49.20%562.37M | 46.91%2.93B | --1.29B | 8.44%988.21M |
Operating income | 69.45%2.81B | 91.34%5.61B | 67.66%1.66B | 46.91%2.93B | 8.44%988.21M | |||||
Cost of sales | ---- | -103.27%-2.45B | ---- | -170.72%-4.8B | ---- | -210.85%-1.21B | ---- | -163.82%-1.77B | ---- | -42.26%-387.96M |
Operating expenses | -103.27%-2.45B | -170.72%-4.8B | -210.85%-1.21B | -163.82%-1.77B | -42.26%-387.96M | |||||
Gross profit | -20.98%356.27M | -29.96%811.98M | -24.89%450.88M | -12.41%1.16B | -6.00%600.26M | |||||
Selling expenses | ---- | -14.03%-902K | ---- | ---2.01M | ---- | ---791K | ---- | ---- | ---- | ---- |
Administrative expenses | ---- | -5.16%-38.84M | ---- | -38.11%-106.67M | ---- | -32.38%-36.93M | ---- | -11.35%-77.23M | ---- | 6.14%-27.9M |
Impairment and provision | ---- | 52.45%-1.73M | ---- | -27.57%-12.82M | ---- | -945.40%-3.64M | ---- | -484.42%-10.05M | ---- | 31.09%-348K |
-Other impairment is provision | ---- | 52.45%-1.73M | ---- | -27.57%-12.82M | ---- | -945.40%-3.64M | ---- | -484.42%-10.05M | ---- | 31.09%-348K |
Operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---52.3M |
Special items of operating profit | ---- | 95.89%53.58M | ---- | -0.46%52.21M | ---- | 35.36%27.35M | ---- | 222.52%52.45M | ---- | 92.40%20.2M |
Operating profit | -15.68%368.38M | -33.96%742.7M | -19.09%436.87M | -1.48%1.12B | -12.76%539.92M | |||||
Financing cost | ---- | 11.14%-34.08M | ---- | 28.68%-68.28M | ---- | ---38.36M | ---- | ---95.74M | ---- | ---- |
Share of profits of associates | ---- | 33.85%174K | ---- | -41.62%1.81M | ---- | -84.92%130K | ---- | 750.82%3.1M | ---- | 635.40%862K |
Share of profit from joint venture company | ---- | ---- | ---- | 288.86%37.37M | ---- | --2.94M | ---- | --9.61M | ---- | ---- |
Earning before tax | -16.71%334.47M | -31.49%713.59M | -25.74%401.58M | -8.78%1.04B | -1.72%540.78M | |||||
Tax | ---- | 20.96%-81.6M | ---- | 31.28%-179.69M | ---- | 23.91%-103.24M | ---- | 9.34%-261.47M | ---- | 4.70%-135.67M |
After-tax profit from continuing operations | -15.24%252.87M | -31.56%533.9M | -26.35%298.35M | -8.60%780.06M | -0.69%405.11M | |||||
Earning after tax | -3.61%392.7M | -15.24%252.87M | -26.12%122.43M | -31.56%533.9M | -35.11%407.4M | -26.35%298.35M | -3.84%165.72M | -8.60%780.06M | 627.8M | -0.69%405.11M |
Minority profit | ---- | 300.99%4.28M | ---- | 628.62%8.64M | ---- | ---2.13M | ---- | ---1.64M | ---- | ---- |
Profit attributable to shareholders | -17.27%248.59M | -32.80%525.26M | -25.83%300.47M | -8.41%781.69M | -0.69%405.11M | |||||
Basic earnings per share | -20.00%0.12 | -35.90%0.25 | -25.00%0.15 | -9.30%0.39 | 0.00%0.2 | |||||
Diluted earnings per share | -20.00%0.12 | -35.90%0.25 | -25.00%0.15 | -9.30%0.39 | 0.00%0.2 | |||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | HKAS | HKAS | HKAS | CAS (2007) | HKAS | HKAS | HKAS | CAS (2007) | HKAS |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | Ernst & Young Huaming (Special General Partnership), Ernst & Young | -- | -- | -- | Ernst & Young Huaming (Special General Partnership), Ernst & Young | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data